Charlie Michael Baker, 18, from Preston, Lancashire, began receiving dermal fillers in March 2024 to address insecurities ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase ...

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

Influencer and author Charlie Michael Baker, 18, from Preston, Lancashire, first got dermal fillers in March 2024 after ...

Results showed 66% of patients treated with icotrokinra achieved an ss-IGA score of 0/1 and 77% achieved a sPGA-G score of 0/1, compared with 11% and 21% receiving placebo, respectively, at week 16.

Treating psoriasis, a chronic inflammatory skin condition characterized by thick, scaly, red patches that can be itchy and painful, can be challenging if it appears on both the body and the scalp.

Learn all about psoriasis, a chronic inflammatory disease, including common symptoms, treatments, plus which diet and ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%.